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BY FREDERICK P.  GAY,  M.D.,  AND HENRY T.  CHICKERING, M.D. 
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Previous  work  has  shown  that  the  occurrence  of a  specific pre- 
cipitin  reaction between a  serum of one animal  species and  its anti- 
serum  may  result  in  a  very  definite action  on  normal  or  immune 
antibodies comained  in the first  (precipitinogenic)  serum. 
Such  studies  were inspired by the work of Camus  and  Gley  (i), Kossel  (2), 
and  Bordet  (3), who had shown that antihemolysins were formed by immuniza- 
tion against a  hemolytic serum, and were designed to  determine whether  similar 
antibodies  could be produced to antitoxins, agglutinir~s,  precipitins, and  the  like. 
Kraus and Eisenberg (4)  succeeded in producing an antilactoserum, the action 
of which was apparently due to the carrying down of the precipitin of the lacto- 
serum with its  precipitinogen which  had  been  allowed to  interact  with the  anti- 
lactoserum.  In other words, the serum of a  rabbit immunized against milk when 
precipitated by the serum of a goat immunized against rabbit serum removes the 
precipitin  for  milk  from  the  lactoserum.  The  first  combination  was  for  some 
reason  not  effective when  a  dog-antirabbit  serum  was  employed.  These  same 
authors  failed,  however,  to  demonstrate  fixation  of  tetanus  antitoxin  or  of 
typhoid agglutinin in horse  serum after  precipitating the  horse  serum by  means 
of  rabbit-antihorse  serum.  Their failure to  remove the antitoxin was,  however, 
due  to  the  excess  of  precipitinogen  (horse  antitoxin.)  employed,  an  inhibiting 
factor to precipitate formation that was then unknown.  This difficulty  was over- 
come  by  Dehne  and  Hamburger  (5),  who  found  that  diluted  (1:5oo)  horse 
antitoxin  was  entirely removed  from  the  supernatant  fluid on  producing a  pre- 
cipitate with rabbit-antihorse serum.  These experiments were fully corroborated 
by Krans and  Pribram  (6),  Hamburger  (7), and yon Eisler and  Tsuru  (8),  and 
analogous  facts were produced  in respect to  the  fixation of  diphtheria  antitoxin 
in horse  serum by  Weill-Hall6 and  Lemaire  (9)  and  by  Atkinson and  Banzhaf 
(IO).  Experiments which indicate that a similar removal of antitoxin takes place 
in the body of immunized animals were performed with  diphtheria  antitoxin by 
Sacharoff  (II)  and  with tetanus  antitoxin iby Dehne and Hamburger  (5). 
Some difference of opinion exists as to the carrying down of agglutinins with 
a  precipitinogen when antiserum  is added,  the results obtained doubtless  depend- 
ing on  technical  differences.  Thus,  Kraus  and  Eisenberg  (4)  at  first  failed  to 
remove immune agglutinins, but  later  Krans  and  Pribram  (6)  succeeded.  Von 
Eisler and  Tsuru  (8)  and  Landsteiner  and  Pra~ek  (12)  brought  down  normal 
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agglutinins, but the latter at times failed with immune agglutinins.  Wassermann 
and  Bruck  (I3)  failed to  remove antityphoid protective bodies by precipitation 
with rabbit-antigoat serum, whereas some such removal is indicated by the ex- 
periments of Walker  (I4) performed in vivo.  Zebrowski (I5)  failed to remove 
the hemolytic sensitizer (amboceptor) by similar treatment. 
These  facts are of significance in considering the mode of action 
of antisensitizers  (antiamboceptors)  as bearing  on  the  relations  of 
lysins  to  "Border's  fixation bodies," and  particularly  as bearing  on 
the relation of the fixation reaction to the formztion  of specific pre- 
cipitates  (I5).  We do not propose, however, to discuss any of these 
interesting  and  somewhat  puzzling  questions  at  this  time,  but  to 
direct a~tention to the one  fact that an antiserum  (antitoxin,  agglu- 
tinating serum)  when employed as a precipitinogen by the addition of 
an  h,omologous  antiserum  (precipitin)  may yield to  the  precipitate 
its  entire  content  of antibody. 
It  is the  reverse of this  reaction  which  we wish to  describe,  em- 
ploying a~tipneumococcus serum as precip~tin  and producing a  pre- 
cipitate  by the  addition  of  an  extract  of  the  pneumococcus.  We 
find that such a  precipitate brings down more or less completely ~he 
antibodies  which  protect  animals  against  pneumococcus  infection. 
Owing  to  a  corresponding  reversal  of  the  relative  dosage  of  the 
reacting  substances,  this  reaction  becomes  at  once  of  practical  as 
well as of theoretical interest.  It enables us not only to concentrate 
the specific antibodies of the  antipneumococcus serum  in small vol- 
ume, but, as we shall see, in a fluid of extremely low protein content. 
Although  bacterial  precipi,  tins  were  the  first  to  be  described 
(Kraus,  1897  (I7)),  interest in them has  for practical reasons been 
far exceeded by that taken in the serum and protein precipi,tins  later 
described  by  Tchistoviteh  (I8)  and  by  Borde~  (I9).  Neufeld 
(2o)  first  described  a  precipitin  for  pneumococcus  extract  in  the 
serum  of  specifically  immunized  animals.  His  observations  were 
extended  by  \Sradsworth  (2I),  by  Panichi  (22),  by  Heyrovsk.~" 
(23) ,  and  by  Norris  (24). 
In our own work we have employed potent antipneumococcus sera 
produced in horses by prolonged treatment with dead and living cul- 
tures of either type I or type II  (25)  strains of pneumococcus.  Such 
sera agglutinate  specifically the type of pneumococcus employed for Frederick P.  Gay and Henry T.  CIdckering.  :~91 
immunization  in  low  dilutions,  but have  no  effect on  other types. 
They further protect mice in  a  dose of  o.2  of  a  cubic  centimeter 
against o.I, or rarely o.5, of a cubic centimeter of a twenty-four hour 
bouillon passage  culture of pneumococeus of which o.ooo,om  of a 
cubic centimeter suffices to kill controls. 
As antigen (precipitinogen)  we have used water-clear extracts of 
dried  and  ground  pneumococci  obtained  by  precipitating  consid- 
erable  amounts  of  washed  concentrated  bouillon  cultures  by  the 
addition of equal parts  of 95  per cent.  alcohol, or,  in later experi- 
ments, by ad4ing them to ten volumes of acetone (56)  (Kahlbaum's 
C.  p.).l  . These extracts  were made in  the manner that  Gay and 
Claypole (27)  have described for producing plain typhoid vaccines, 
and are made by suspending weighed amounts of ground culture in 
carbolated  (o. 5  per cent.)  saline solution  in  the proportion  of one 
milligram to one cubic centimeter, shaking at intervals at a tempera- 
ture of 37 °  C.  for from three to six hours, and then allowing them 
to remain in the ice box over night.  On the following day the sus- 
pended mixture  is  vigorously centrifugalized until  the supernatant 
fluid  is  cloudless  and  water-clear,  or  at  most  sl,ightly  opalescent. 
Such supernatant fluids from ground pneumococci are very toxic for 
mice,  distinctly  more  so  than  the  bacterial  sediment  from  which 
they have been separated. 
This  clear  antigen  gives  a  distinct  precipitin  reaction  with  one 
cubic centimeter of  strong  immune serum in  a  dose of o.oI  of  a 
cubic centimeter or less, when read from the sediment after twenty- 
four  hours  at  room  temperature.  The  maximal  precipitate  and 
rapidity of reaction are produced by the addition of from o.3 to one 
cubic centimeter of the antigen when added in a  single dose.  We 
have as yet no information at hand as .to the zone of inhibition or 
resolution of the precipitate in an excess of antigen.  In producing 
precipitates to test  for protective purposes our method has been to 
endeavor to produce the maximum precipitate from a  given amount 
of immune serum.  For this purpose we have added the antigen in 
8ivided doses, all'owing the cloudy or flocculent precipitate to  form 
for from a  few minutes to several hours, centrifugalizing, and then 
i This was  done  at the  suggestion of  Dr.  Van  Slyke. 392  Protective Bodies in Antipneumococcus  Serum. 
adding more precipitinogen to  the supernatant serum until  no  fur- 
ther cloud is produced. 
We have by no means  fully determined the ideal conditions  for 
producing 'the maximal precipitate, or perhaps, more correctly speak- 
ing,  the optimal protein complex in a  precipitate, as is  indicated by 
the considerable variations  in  the  total  nitrogen  determinations  of 
our washed precipitates.  Nor have we in all instances succeeded in 
bringing down all the protective antibodies in our precipitates.  The 
fact,  however,  that  we  have  repeatedly  found  such  precipitates, 
washed free of serum, to contain as much protective value in aliquot 
parts as the immune serum, seems to us to justify this communica- 
tion, pending a  greater uniformity of results. 
EXPERIMENTAL. 
Experiment /.--To 2o c.c.  of antipneumococcus serum  (type I, lot I4, Dec. 6, 
1913)  were added 6 c.c.  of clear carbolated extract of dried pneumococci.  An 
immediate voluminaus  precipitate occurred.  This was centrifugalized five  min- 
utes later and another 6  c.c.  of  antigen were  added  to  the supernatant fluid.  A 
slow  cloudiness  appeared  which  was  allowed  to  form  for  two  hours  at  37 °  C. 
The  second supernatant fluid in a  dose of  I  c.c.  gave no  further precipitate with 
doses of  from o.I  to  I  c.e.  of antigen.  The combined precipitates were shaken in 
2o e.c.  of carbolated saline, centrifugalized, and resuspended.  2o e.c.  of the same 
specimen of  antipneumocoecus serum  were  diluted pari passu with the above by 
addition  of  two  doses  of  6  c.c.  each  of  carbolated  saline  solution  instead  of 
antigen. 
One-half the  above  washed  precipitate  was  dissolved  by  2  c.c.  of fl-  0-  sodium 
hydrate.  It  was  further  diluted  with  saline until  0.5  c.c.  of  the  solution  corre- 
sponded  to  the  precipitate  derived  from  o.2  c.c.  of  original  serum.  The  undis- 
solved precipitate, the original diluted serum, and the exhausted  (precipitin-free) 
serum  were  also  made  up  to  corresponding  volume  (o.5  c.c.  equals  o.2  c.c.  of 
original serum). 
A  Kjeldahl  determination by  Mr.  Cullen  gave  a  total  nitrogen  in  the  undis- 
solved precipitate,  indicating a  protein  content of  0.34  per cent. 
With  these  mixtures  the  following  experiments  were  performed  on  mice 
(tables I,  II, and III). TABLE  I. 
A.  Protective Experiment with Serum and Derivatives Mixed in a Fixed Amount 
with Decreasing  Amounts of Dilutions of a Twenty-Four Hour Bouillon 
Culture of Pneumococcus, Type I, 96-I,  2 in a Total  Volume of o.5 
C.C.  The Mixtures  Were Injected Intraperitoneally in Mice. 
Mouse.  "Protective  fluid.  Culture.  Result. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
12 
I3 
14 
15 
16 
I7 
x8 
x9 
Control 
Control 
Control 
Original serum 0.2 in o.5 c.c. 
Original serum o.2 in o.5 c.c. 
Original serum o.2 in o.5 c.c. 
Original serum o.2 in o.5 c.c. 
Exhausted  serum o.2 in o.5 c.c. 
Exhausted  serum o.2 in o.5 c.c. 
Exhausted  serum o.2 in o.5 c.c. 
Exhausted  serum o.2 in o.5 c.c. 
t 
Whole washed  precipitate o.2 in o. 5  c.c. 
Whole washed precipitate 0.2 in o.5 c.c. 
Whole washed precipitate 0.2 in o. 5  c.c. 
Whole washed precipitate o.2 in o.5 c.c. 
Dissolved precipitate o.2 in o.5 c.c. 
Dissolved precipitate 0.2 in o.5 c.c. 
Dissolved precipitate o.2 in o.5 c.c. 
Dissolved precipitate o.2 in o.5 c.c. 
O.O00I  C.C. 
O.O000I  C.C. 
O.O0000I  C.C. 
0.5  c.c. 
0.I  e.c. 
O.OI  C.C. 
O.OOI  C.C. 
0.5  e.c. 
0.I  c.e. 
o.oI  e.c. 
o.ool  c.c. 
0. 5  c.e. 
0.I  C.C. 
O.OI  C.C. 
O.OOI  C.C. 
o.5  c.c. 
O.I  C.C. 
O.OI  C.C. 
0.001  C.C. 
Died,  45 hrs. 
Died,  45 hrs. 
Died,  45 hrs. 
Died, 45 hrs. 
Survived. 
Died, 34 hrs. 
Survived. 
Died,  20 hrs. 
Died,  45 hrs. 
Survived. 
Survived. 
Died,  45 hrs. 
Survived. 
Survived. 
Died, 45 hrs. 
Died,  45 hrs. 
Survived. 
Survived. 
Died,  4  dys. 
TABLE  II. 
B.  Protective Experiment with Fixed Dose of Culture  and Decreasing  Doses of 
Serum and  Serum Derivatives. 
Mouse. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
I3 
I4 
I5 
16 
x7 
Protective  fluid.  Total  volume 0.5 c.c. 
Original serum o.I  c.c. 
Original serum 0.05  c.c. 
Original serum o.o25  c.c. 
Original serum o.o125  c.e. 
•  Original serum 0.00625 c.c. 
Dissolved precipitate o.I  c.c. 
Dissolved precipitate o.o5  c.c: 
Dissolved precipitate o.o25  c.c. 
Dissolved precipitate o.o125  c.c. 
Dissolved precipitate 0.00625  C.C. 
Exhausted  serum o.I  c.c. 
Exhausted  serum o.o5  c.c. 
Exhausted  serum o.o25 c.c. 
Control 
Control 
Control 
Control 
Culture. 
Pneumococcus,  type  I, 
98-I. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.e. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
0.05  c.c. 
O.OOOI  c.c. 
0.OOOOI  c.c. 
0.OO0001  C.C. 
Result. 
Survived. 
Survived. 
Survived. 
Survived. 
Died,  14 dys. 
Survived. 
Survived. 
Survived. 
Survived. 
Survived. 
Survived. 
Died,  36 hrs. 
Died, 36 hrs. 
Died,  20 hrs. 
Died,  18 hrs. 
Died, 40 hrs. 
Died, 48 hrs. 
2 This  indicates  the  ninety-sixth  passage  through  animals  with  a  single passage 
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TABLE  III. 
C.  Duration  of  Protection  Afforded  by  Antipneumococcus  Serum  and  Its 
Precipitate. 
In  this  experiment two  series  of  mice  were given,  respectively,  whole  serum 
and  dissolved precipitate  in a  dose of o.2  c.c.  subcutaneously, and  inoculated  sub- 
sequently at  intervals  with  suitable  controls. 
Series A, on Dec. 15, 1914, was given 0.2  c.c.  of diluted  serum in saline (volume 
o.5  e.c.)  subcutaneously. 
Series  B,  on  the  same  date,  was  given  o.2  e.c.  of  dissolved  precipitate  from 
serum  (o.2 in o.5  c.c.)  subcutaneously. 
Mouse.  Interval.  Dose of culture.  Result. 
A-I 
A-2 
A-3 
A- 4 
A-5 
A-6 
A-7 
A-8 
B-'r 
8-2 
B-3 
B-4 
B-5 
B-6 
B-7 
B-8 
B-9 
4 dys. 
4 dys. 
4 dys. 
8 dys. 
8 dys. 
8 dys. 
IO dys. 
io dys. 
4 dys. 
4 dys. 
4 dys. 
8 dys. 
8 dys. 
8 dys. 
Io dys. 
IO dys. 
IO dys. 
o.z  c.c. 
o.oi  c.c. 
o.ooi  c.cfl 
0.01  C.C. 
O.OOI  2.C. 
0.0001  e.cfl 
0.O00I  C.C. 
O.0000I  e.c. 5 
O.I  C.C. 
O,OI  C.C. 
O.OOI  C.C. 8 
0.0I  C.C. 
O.OOI  C.C. 
O.O00I  C.Cfl 
0.OOI  C.C. 
0.000I  C.C. 
0.0000I  C.C. 5 
Died,  I4 hrs. 
Died,  i8 hrs. 
Survived. 
Died, 20 hrs. 
Died,  Io hrs. 
Survived. 
Survived. 
Survived. 
Died,  18 hrs. 
Died,  18 hrs. 
Survived. 
Died,  io hrs. 
Died,  Io hrs. 
Died,  4 dys. 
Died,  24 hrs. 
Died, 3  °  hrs. 
Died,  42 hrs. 
The  first two sections  of  this  experiment  (A  and  B)  show  that 
the precipitate derived by adding an extract of pneumoeoccus to anti- 
pneumococcus  serum may contain as much protective power against 
pneumococcus  infection in mice as the original serum  from which it 
is derived.  It is active whether employed in its original precipitated 
condition  or dissolved  in a  small amount of alkali.  In this experi- 
ment the duration of the immunity passively conferred by precipitate 
was not so great as when serum was used.  This  failure in durabil- 
ity, however, may well have been due to the fact that the solution of 
a Controls  with doses of 0.0000I  and 0.00000I  c.c.  died  in 40  hrs. 
4 Controls with doses of 0.0000I  and 0.00000I  c.c.  died  in  20  and  48  hrs. 
s Controls with doses of 0.0000I  c.c.  died  in 42  hrs. Frederick P.  Gay and Henry T.  Chickering.  395 
precipitate in an alkali is by no means without  harmful effect on  its 
protective power.  The amount of alkali needed to dissolve the pre- 
cipi¢ate has varied not .only with the apparent opacity of the precip- 
itate  but  also  with  its  age,  freshly  formed  precipitates  being more 
readily  soluble  than  older  ones.  At  all  events  the  addition  of  the 
alkali  has  frequently robbed the  precipitate of  its protective proper- 
ties,  and  it has  likewise a  harmful  effect on the  original  serum.  A 
solution  of  the  precipitate  seemed  desirable  in  view  of  its  possible 
application  by intravenous  injection  in  human  cases  of  pneumonia. 
• It  is  questionable,  however,  if  the  precipitate  itself  would  be  dan- 
gerous  to  employ;  we  have  given  considerable  amounts  to  rabbits 
intravenously  without  ill  effect. 
It seemed to be of  importance,  when employing the  original  pre- 
cipitate  in  protection  against  intraperitoneal  infection  in  mice,  to 
show that the protective effect is not  in some measure due to a  pos- 
sible mechanical effect of the precipitate rather .t~an to specific anti- 
bodies.  This  would  seem  to be  ruled  out  in  the  following  experi- 
ment,  in which  a  precipitate  from a  serum  of  type  I  was  employed 
mixed with cultures  of pneumococci of both type I  and type II. 
Experiment 2.--Protective value of precipitate  1. 6  The dried  culture in this 
experiment  differs  from the  preceding  antigen  in  that  it  was  precipitated  by 
alcohol  directly  from  the  bouillon  culture  without  washing.  An  extract  was 
made in carbolated saline  in  dilution  of I  mgm. to  I  c.c.  This antigen  solution 
was added in doses of 5o and 4o c.c., with 12 hours' interval,  to IOO c.c. of serum 
of type I, lot 3.  Precipitates were produced on each addition,  which  were then 
washed and suspended  in one-fifth the original volume.  Not all  the  precipitate 
was removed from the treated serum,  as could be shown 'by further addition  df 
antigen.  A  Kjeldahl determination of the precipitate diluted  to original volume 
gave a protein content of O.lO8 per cent. 
The protective values of the precipitate concentrated five times, of the precipi- 
tate at original volume,  and of the concentrated  precipitate  dissolved  in  sodium 
hydrate,  ° are compared with the original serum.  Mixtures of the various fluids 
were made with the culture dilutions,  each in  a volume of 0.5  c.c., and injected 
intraperitoneally in mice  (table IV). 
o 0.3 c.c. of  Y sodium hydrate was used to dissolve 5 c.c. of five times concen- 
trated precipitate. 396 
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This experiment indicates the protective value of undissolved pre- 
cipitate  emulsion, shows  its  specificity,  and that  concentration in- 
creases  its  potency.  The  deleterious effect of  solution in  sodium 
hydrate !s also shown. 
We are at present engaged in determining other methods of dis- 
solving the precipitate which may have no effect on the protective 
bodies.  Our experiments show further that the agglutinins as well 
as  the  protective bodies  are  brought  down  with  the  precipitate. 
Preliminary experiments indicate that a comparison of the protective 
value of precipitates with that of the original serum may be made 
more convincing  by employing rabbits instead of mice.  It is at least 
evident that a simultaneous injection of serum or of the precipitate 
will protect rabbits  from an intravenous dose of the pneumococcus 
that  is  many times  the  fatal  dose.  The  precipitates  have  shown 
themselves to ~be as protective as the original serum in these animals, 
although the end-point of the protective value has not been reached 
in our experiments to the present time. 
TABLE  V. 
Protein Content  of Antipneumococcus  Serum before  and after Precipitation,  and 
of Its Precipitates  with Indication  of Protective  Value  of Precipitates. 
Precipitate lot. 
I  t 
I s  0.34% 
I S  o.x8% 
14 
15  0.09% 
I s  0.I08% 
17 o.io~% 
II x o.21% 
II 4 o.I57% 
Protein content, 
Original serum.  Antigen. 
5.76% 
6.49%  0.015% 
5.9  %  0.022% 
5.9  % 
5.56%  0.022% 
Exhausted  serum. 
7.0  % 
7.I9% 
5.07% 
5.9o% 
5.7z% 
Protective value of precipitate. 
Protects well. 
Protects well. 
Partial protection,  v 
Partial protection3 
Partial protection3 
Protects well. 
Protects well. 
Does not protect. 
Protects well. 
It remains to discuss the relative protein contents of serum and 
precipitate.  Our results here are somewhat varying and fragmen- 
tary, but show that the protein content of the precipitate as compared 
with serum is surprisingly low.  There would, moreover, seem to be 
no necessarily direct relation between protein content and protective 
value.  We are indebted to Mr.  Cullen for the Kjeldahl determina- 
r The failure to demonstrate good protection in this serum is probably due  to 
the fact that only the dissolved sodium hydrate precipitate was tested. 398  Protective Bodies in Antipneumococcus  Serum. 
tions  of  total  nitrogen  content  on  which these  figures  are  based. 
The estimates  were made in  duplicate and  usually  from five cubic 
centimeters each of a  dilution of each fluid. 
It  will  be  noted  from  table  V  that  in  all  instances  of  pre- 
cipitates  from antipneumococcus sera of type I,  where only partial 
protection was  obtained by the precipitates, the original precipitate 
emulsions were not tested, but only the precipitates after solution in 
sodium hydrate which, as has been evidenced, may destroy the pro- 
tective power in precipitate or in serum. 
The average protein content of more or less perfectly protective 
precipitates is, as will be noted, very low, ranging from o.o9 to o.34 
per cent., or from one-seventieth to one-thirty-second of the amount 
of  protein  in  the  original  serum  in  those  instances  in  which  full 
computation was made.  The obvious value of the possible employ- 
ment of con.centrated immune bodies in a solu.tion of such low protein 
concentration for intravenous injection in human beings is apparent. 
The avoidance of serum sickness and of the possible  formation of 
antagonistic bodies  seems possible  by this  means.  The  advantage 
of this method of concentration of the protective bodies over con- 
centration by chemical precipitation lies not only in the low protein 
content of the precipitate, but also in the fact that it may be produced 
rapidly and under conditions of absolute asepsis. 
CONCLUSIONS. 
The  addition  of  a  water-clear  extract  of  pneumococci  to 
homologous  antiserum  produces  a  voluminous  precipitate  which 
carries down with it the agglutinins  and practically the totality of 
the  protective  bodies  against  pneumococcus  infection  in  animals. 
This precipitate when washed and resuspended in saline solution to 
the original  volume of serum protects as well as  the whole serum. 
The protein content of such solutions has varied from o.o9 to 0.34 
per cent,, as contrasted with about 6  per cent. in the original serum. 
The solution of this precipitate is not necessary to insure protection, 
and when produced by d'ilute alkali  (sodium hydrate) frequently de- 
stroys the immune bodies. 
In conclusion the senior author wishes to express his appreciation 
of the courtesy which Dr. Cole has shown in placing the facilities of 
the hospital at his disposal  for this  work. Frederick  P.  Gay  and  Henry  T.  Chickering.  399 
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